New York, USA – February 23, 2021 – Creative Proteomics has more than 10 years of experience in providing advanced multi-omics services and support customers with comprehensive metabolomics solutions. The company has recently launched a short-chain fatty acid analysis service to help accelerate research on the physiological roles of short-chain fatty acids in a variety of cellular and molecular systems, such as affecting immune regulation, inhibiting the production of anti-inflammatory factors, blocking tumor cell proliferation, and controlling proto-oncogene expression.
Short-chain fatty acids (SCFA) are organic fatty acids with a carbon atomic number of 2 to 6, mainly including acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, iso-valeric acid, caproic acid, and iso-caproic acid. SCFA is produced primarily by the digestion of indigestible sugars such as dietary fiber, resistant starch, and oligosaccharides in the colon by lactic acid bacteria, bifidobacteria and other beneficial bacteria. Acetic acid, propionic acid, and butyric acid have the highest content in biological samples, which account for more than 85% of SCFA.
SCFA has a variety of important biological functions in organisms. The main functions are:
1. Provide energy: SCFA can provide energy for colon cells, mucosal epithelial cells, and muscles. Among them, the glucose produced by propionic acid in gluconeogenesis can meet 30%-50% of the energy requirements of animals. Butyric acid is converted into ß-hydroxybutyric acid to provide energy for the body. Acetic acid, propionic acid and butyric acid can be used as important energy sources after being absorbed by intestinal mucosal epithelial cells.
2. Maintain water and electrolyte balance
3. Improve intestinal blood circulation
4. Stimulate the secretion of gastrointestinal hormones (such as gastrin and motilin)
5. Regulate gene expression
Creative Proteomics has provided SCFA analysis services for the National Institutes of Health, the National Institute of Allergy and Infectious Diseases (NIAID), and the Barrier Immunology Department of the Viral Disease Laboratory, accelerating the research on the role of SCFA metabolites produced by microorganisms on gastrointestinal (GI) immunity and epithelial barrier maintenance.
The concentration of SCFA can be quantified by combining gas chromatography (GC) with other techniques. Creative Proteomics provides the most advanced gas separation platform to identify and quantify a wide range of volatile and semi-volatile organic compounds. The uniqueness of its method lies in its high sensitivity, which can accurately quantify various trace amounts of SCFAs in 0.1 g of feces and 50 microliters of serum.
“Our specialized service is designed to provide a versatile and reliable platform for metabolomic analysis. Over the past ten years, we have helped clients complete hundreds of projects, from project design and experiment to interpretation of results and bioinformatics analysis,” stated Creative Proteomics’s executive VP.
If you are interested to learn more, please visit https://www.creative-proteomics.com.
About Creative Proteomics
Established in 2004, Creative Proteomics has gradually grown into an integrated service provider with metabolomics, lipidomics, and bioinformatics analysis services to researchers in pharmaceutical, biotechnology, agriculture, and nutrition industries, as well as academic and government organizations. With a continued focus on quality, Creative Proteomics is proud to satisfy our clients’ needs both at home and abroad, covering more than 50 countries and districts.